Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Jamba, Inc. Announces Resignation of Robert C. Kagle from Board of Directors
Jamba, Inc., has announced that Robert C. Kagle resigned from its board of directors on August 12, 2009 with immediate effect.
- Afexa Life Sciences Announces FY09 Q3 Results
Afexa Life Sciences Inc., has announced their FY09 Q3 results, reporting a 85% revenue increase to $6.2 million in the three months ended June 30, 2009 from $3.4 million in the corresponding period of fiscal 2008. The net loss for the fiscal 2009 third quarter was $1.1 million ($0.01 per basic share), an improvement from the net loss of $2.0 million ($0.02 per basic share) in the same three months last year.
- Afexa Life Sciences Announces FY09 Q3 Results
Afexa Life Sciences Inc., has announced their FY09 Q3 results, reporting a 85% revenue increase to $6.2 million in the three months ended June 30, 2009 from $3.4 million in the corresponding period of fiscal 2008. The net loss for the fiscal 2009 third quarter was $1.1 million ($0.01 per basic share), an improvement from the net loss of $2.0 million ($0.02 per basic share) in the same three months last year.
- Afexa Life Sciences Announces FY09 Q3 Results
Afexa Life Sciences Inc., has announced their FY09 Q3 results, reporting a 85% revenue increase to $6.2 million in the three months ended June 30, 2009 from $3.4 million in the corresponding period of fiscal 2008. The net loss for the fiscal 2009 third quarter was $1.1 million ($0.01 per basic share), an improvement from the net loss of $2.0 million ($0.02 per basic share) in the same three months last year.
- Afexa Life Sciences Announces FY09 Q3 Results
Afexa Life Sciences Inc., has announced their FY09 Q3 results, reporting a 85% revenue increase to $6.2 million in the three months ended June 30, 2009 from $3.4 million in the corresponding period of fiscal 2008. The net loss for the fiscal 2009 third quarter was $1.1 million ($0.01 per basic share), an improvement from the net loss of $2.0 million ($0.02 per basic share) in the same three months last year.
- National Enzyme Company Announces TGA Recertification
National Enzyme Company has announced their TGA recertification after a recent audit performed by TGA representatives.
- National Enzyme Company Announces TGA Recertification
National Enzyme Company has announced their TGA recertification after a recent audit performed by TGA representatives.
- National Enzyme Company Announces TGA Recertification
National Enzyme Company has announced their TGA recertification after a recent audit performed by TGA representatives.
- National Enzyme Company Announces TGA Recertification
National Enzyme Company has announced their TGA recertification after a recent audit performed by TGA representatives.
- National Enzyme Company Announces TGA Recertification
National Enzyme Company has announced their TGA recertification after a recent audit performed by TGA representatives.
- China-Biotics, Inc. Reports FY10 Q1 Results
China-Biotics, Inc., has announced their FY10 Q1 results, reporting net sales increased 35.5% to $15.4 million from $11.4 million a year ago. The increase resulted from an increase in sales volume from new products, most of which were sold in the Company's Shining-branded retail outlets, significant growth in the bulk additive business and sales price increases on bulk additives products.
- China-Biotics, Inc. Reports FY10 Q1 Results
China-Biotics, Inc., has announced their FY10 Q1 results, reporting net sales increased 35.5% to $15.4 million from $11.4 million a year ago. The increase resulted from an increase in sales volume from new products, most of which were sold in the Company's Shining-branded retail outlets, significant growth in the bulk additive business and sales price increases on bulk additives products.
- China-Biotics, Inc. Reports FY10 Q1 Results
China-Biotics, Inc., has announced their FY10 Q1 results, reporting net sales increased 35.5% to $15.4 million from $11.4 million a year ago. The increase resulted from an increase in sales volume from new products, most of which were sold in the Company's Shining-branded retail outlets, significant growth in the bulk additive business and sales price increases on bulk additives products.
- China-Biotics, Inc. Reports FY10 Q1 Results
China-Biotics, Inc., has announced their FY10 Q1 results, reporting net sales increased 35.5% to $15.4 million from $11.4 million a year ago. The increase resulted from an increase in sales volume from new products, most of which were sold in the Company's Shining-branded retail outlets, significant growth in the bulk additive business and sales price increases on bulk additives products.
- GeoPharma Announces FY10 Q1 Results
GeoPharma, Inc., has announced their FY10 Q1 results, reporting revenues from continuing operations in the Manufacturing Segment decreased from approximately $6.2 million dollars to approximately $4.6 versus the first quarter of fiscal year 2009.
- GeoPharma Announces FY10 Q1 Results
GeoPharma, Inc., has announced their FY10 Q1 results, reporting revenues from continuing operations in the Manufacturing Segment decreased from approximately $6.2 million dollars to approximately $4.6 versus the first quarter of fiscal year 2009.
- GeoPharma Announces FY10 Q1 Results
GeoPharma, Inc., has announced their FY10 Q1 results, reporting revenues from continuing operations in the Manufacturing Segment decreased from approximately $6.2 million dollars to approximately $4.6 versus the first quarter of fiscal year 2009.
- Skinny Nutritional Corp. Reports FY09 Q2 Revenues
Skinny Nutritional Corp., has announced their revenues for FY09 Q2, reporting net revenues of $1,190,960 for the three months ending June 30, 2009. This represents an increase of $1,011,374 (563%) over revenues for the three months ending June 30, 2008.
- Skinny Nutritional Corp. Reports FY09 Q2 Revenues
Skinny Nutritional Corp., has announced their revenues for FY09 Q2, reporting net revenues of $1,190,960 for the three months ending June 30, 2009. This represents an increase of $1,011,374 (563%) over revenues for the three months ending June 30, 2008.
- Skinny Nutritional Corp. Reports FY09 Q2 Revenues
Skinny Nutritional Corp., has announced their revenues for FY09 Q2, reporting net revenues of $1,190,960 for the three months ending June 30, 2009. This represents an increase of $1,011,374 (563%) over revenues for the three months ending June 30, 2008.
- E.T. Horn Selected For Exclusive Omega Fields Distribution
The E.T. Horn Company has announced that it will distribute animal nutrition products and ingredients from Omega Fields throughout Arizona and California.
- E.T. Horn Selected For Exclusive Omega Fields Distribution
The E.T. Horn Company has announced that it will distribute animal nutrition products and ingredients from Omega Fields throughout Arizona and California.
- E.T. Horn Selected For Exclusive Omega Fields Distribution
The E.T. Horn Company has announced that it will distribute animal nutrition products and ingredients from Omega Fields throughout Arizona and California.
- Major investment for Danisco in the fast-growing cultures market
Danisco has announced investments totalling 60 million euros that will add more than 2,000 tonnes to its existing cultures production capacity over the next three years. These investments will meet growing global demand for frozen and freeze-dried Direct Vat Inoculants (DVI) and reinforce Danisco’s leading market position as a cultures supplier.
- Major investment for Danisco in the fast-growing cultures market
Danisco has announced investments totalling 60 million euros that will add more than 2,000 tonnes to its existing cultures production capacity over the next three years. These investments will meet growing global demand for frozen and freeze-dried Direct Vat Inoculants (DVI) and reinforce Danisco’s leading market position as a cultures supplier.
- Major investment for Danisco in the fast-growing cultures market
Danisco has announced investments totalling 60 million euros that will add more than 2,000 tonnes to its existing cultures production capacity over the next three years. These investments will meet growing global demand for frozen and freeze-dried Direct Vat Inoculants (DVI) and reinforce Danisco’s leading market position as a cultures supplier.
- Major investment for Danisco in the fast-growing cultures market
Danisco has announced investments totalling 60 million euros that will add more than 2,000 tonnes to its existing cultures production capacity over the next three years. These investments will meet growing global demand for frozen and freeze-dried Direct Vat Inoculants (DVI) and reinforce Danisco’s leading market position as a cultures supplier.
- BioGaia Issues Interim report
Biogaia reports net sales of SEK 112.4 million (72.4), an increase of SEK 40.0 million (55%) over prior year, with profit before tax of SEK 31.3 million (13.6), an increase of SEK 17.7 million.
- BioGaia Issues Interim report
Biogaia reports net sales of SEK 112.4 million (72.4), an increase of SEK 40.0 million (55%) over prior year, with profit before tax of SEK 31.3 million (13.6), an increase of SEK 17.7 million.
- BioGaia Issues Interim report
Biogaia reports net sales of SEK 112.4 million (72.4), an increase of SEK 40.0 million (55%) over prior year, with profit before tax of SEK 31.3 million (13.6), an increase of SEK 17.7 million.
- BioGaia Issues Interim report
Biogaia reports net sales of SEK 112.4 million (72.4), an increase of SEK 40.0 million (55%) over prior year, with profit before tax of SEK 31.3 million (13.6), an increase of SEK 17.7 million.
- ChromaDex Reports Second Quarter 2009 Financial Results
ChromaDex Corporation has announced FY09 Q2 results, reporting a net loss attributable to common stockholders of $0.01 per share for the thirteen week period ended July 4, 2009, with cash, cash equivalents, and marketable securities totaling $606,575. The company recorded revenue of $1,342,716 as compared to $1,198,885 for the same period in 2008.
- ChromaDex Reports Second Quarter 2009 Financial Results
ChromaDex Corporation has announced FY09 Q2 results, reporting a net loss attributable to common stockholders of $0.01 per share for the thirteen week period ended July 4, 2009, with cash, cash equivalents, and marketable securities totaling $606,575. The company recorded revenue of $1,342,716 as compared to $1,198,885 for the same period in 2008.
- ChromaDex Reports Second Quarter 2009 Financial Results
ChromaDex Corporation has announced FY09 Q2 results, reporting a net loss attributable to common stockholders of $0.01 per share for the thirteen week period ended July 4, 2009, with cash, cash equivalents, and marketable securities totaling $606,575. The company recorded revenue of $1,342,716 as compared to $1,198,885 for the same period in 2008.
- ChromaDex Reports Second Quarter 2009 Financial Results
ChromaDex Corporation has announced FY09 Q2 results, reporting a net loss attributable to common stockholders of $0.01 per share for the thirteen week period ended July 4, 2009, with cash, cash equivalents, and marketable securities totaling $606,575. The company recorded revenue of $1,342,716 as compared to $1,198,885 for the same period in 2008.
- Perrigo Reports Record FY09 Q4 and Full Year Results
Perrigo Company has announced their FY09 Q4 and full year results, reporting net sales from continuing operations for the fourth quarter of fiscal 2009 were $508 million, an increase of 7%. Reported income from continuing operations was $32 million, or $0.35 per share, relatively flat compared with $32 million, or $0.34 per share, a year ago. Excluding charges as outlined in Table II at the end of this release, fourth quarter fiscal 2009 adjusted income from continuing operations was $47 million, or $0.50 per share.
- Perrigo Reports Record FY09 Q4 and Full Year Results
Perrigo Company has announced their FY09 Q4 and full year results, reporting net sales from continuing operations for the fourth quarter of fiscal 2009 were $508 million, an increase of 7%. Reported income from continuing operations was $32 million, or $0.35 per share, relatively flat compared with $32 million, or $0.34 per share, a year ago. Excluding charges as outlined in Table II at the end of this release, fourth quarter fiscal 2009 adjusted income from continuing operations was $47 million, or $0.50 per share.
- Perrigo Reports Record FY09 Q4 and Full Year Results
Perrigo Company has announced their FY09 Q4 and full year results, reporting net sales from continuing operations for the fourth quarter of fiscal 2009 were $508 million, an increase of 7%. Reported income from continuing operations was $32 million, or $0.35 per share, relatively flat compared with $32 million, or $0.34 per share, a year ago. Excluding charges as outlined in Table II at the end of this release, fourth quarter fiscal 2009 adjusted income from continuing operations was $47 million, or $0.50 per share.
- InnoVactiv and WEDAR Teams Up to Position InSea²™ on Chinese and Taiwanese Markets
innoVactiv and WEDAR Biotechnology Co., have announced a collaboration to market innoVactiv's ingredient InSea2™ in Taiwan as well as in China. The exclusive agreement with WEDAR is for an initial five-year term.
- InnoVactiv and WEDAR Teams Up to Position InSea²™ on Chinese and Taiwanese Markets
innoVactiv and WEDAR Biotechnology Co., have announced a collaboration to market innoVactiv's ingredient InSea2™ in Taiwan as well as in China. The exclusive agreement with WEDAR is for an initial five-year term.
- InnoVactiv and WEDAR Teams Up to Position InSea²™ on Chinese and Taiwanese Markets
innoVactiv and WEDAR Biotechnology Co., have announced a collaboration to market innoVactiv's ingredient InSea2™ in Taiwan as well as in China. The exclusive agreement with WEDAR is for an initial five-year term.
- InnoVactiv and WEDAR Teams Up to Position InSea²™ on Chinese and Taiwanese Markets
innoVactiv and WEDAR Biotechnology Co., have announced a collaboration to market innoVactiv's ingredient InSea2™ in Taiwan as well as in China. The exclusive agreement with WEDAR is for an initial five-year term.
- InnoVactiv and WEDAR Teams Up to Position InSea²™ on Chinese and Taiwanese Markets
innoVactiv and WEDAR Biotechnology Co., have announced a collaboration to market innoVactiv's ingredient InSea2™ in Taiwan as well as in China. The exclusive agreement with WEDAR is for an initial five-year term.
- LifeVantage Enters International Market
LifeVantage Corporation has announced that independent distributor applications and orders are being accepted in Mexico in anticipation of a launch late this summer.
- LifeVantage Enters International Market
LifeVantage Corporation has announced that independent distributor applications and orders are being accepted in Mexico in anticipation of a launch late this summer.
- LifeVantage Enters International Market
LifeVantage Corporation has announced that independent distributor applications and orders are being accepted in Mexico in anticipation of a launch late this summer.
- Former Country Life Vitamins Executive Seeks to Acquire Nutraceutical International Corp.
Ryan Drexler, a former senior executive and equity owner of market-leading Country Life Vitamins and holder of 341,000 shares, or 3.1% of the outstanding common stock of Nutraceutical International Corp., today announced his proposal to acquire all of the outstanding shares of Nutraceutical International Corp., in a negotiated all-cash transaction of $10.75 per share.
- Former Country Life Vitamins Executive Seeks to Acquire Nutraceutical International Corp.
Ryan Drexler, a former senior executive and equity owner of market-leading Country Life Vitamins and holder of 341,000 shares, or 3.1% of the outstanding common stock of Nutraceutical International Corp., today announced his proposal to acquire all of the outstanding shares of Nutraceutical International Corp., in a negotiated all-cash transaction of $10.75 per share.
- Former Country Life Vitamins Executive Seeks to Acquire Nutraceutical International Corp.
Ryan Drexler, a former senior executive and equity owner of market-leading Country Life Vitamins and holder of 341,000 shares, or 3.1% of the outstanding common stock of Nutraceutical International Corp., today announced his proposal to acquire all of the outstanding shares of Nutraceutical International Corp., in a negotiated all-cash transaction of $10.75 per share.
- Baywood International, Inc. Announces Shareholder Update and FY09 Q2 Results
Baywood International, Inc., has announced their FY09 Q2 results, reporting unaudited sales for the three and six months ended June 30, 2009 were $1,189,000 and $1,890,000, respectively, compared to zero for the same periods last year.
- Baywood International, Inc. Announces Shareholder Update and FY09 Q2 Results
Baywood International, Inc., has announced their FY09 Q2 results, reporting unaudited sales for the three and six months ended June 30, 2009 were $1,189,000 and $1,890,000, respectively, compared to zero for the same periods last year.
- Baywood International, Inc. Announces Shareholder Update and FY09 Q2 Results
Baywood International, Inc., has announced their FY09 Q2 results, reporting unaudited sales for the three and six months ended June 30, 2009 were $1,189,000 and $1,890,000, respectively, compared to zero for the same periods last year.
- NBTY Acquisition of Julian Graves Formally Approved by UK Competition Commission
NBTY, Inc., has announced that its acquisition of Julian Graves has been formally cleared in the United Kingdom by the UK Competition Commission.
- NBTY Acquisition of Julian Graves Formally Approved by UK Competition Commission
NBTY, Inc., has announced that its acquisition of Julian Graves has been formally cleared in the United Kingdom by the UK Competition Commission.
- NBTY Acquisition of Julian Graves Formally Approved by UK Competition Commission
NBTY, Inc., has announced that its acquisition of Julian Graves has been formally cleared in the United Kingdom by the UK Competition Commission.
- Manitoba Harvest Welcomes New Marketing Manager to Team
Manitoba Harvest Hemp Foods & Oils has announced that Kelly Saunderson has taken over as the Marketing Manager.
- Manitoba Harvest Welcomes New Marketing Manager to Team
Manitoba Harvest Hemp Foods & Oils has announced that Kelly Saunderson has taken over as the Marketing Manager.
- Manitoba Harvest Welcomes New Marketing Manager to Team
Manitoba Harvest Hemp Foods & Oils has announced that Kelly Saunderson has taken over as the Marketing Manager.
- Manitoba Harvest Welcomes New Marketing Manager to Team
Manitoba Harvest Hemp Foods & Oils has announced that Kelly Saunderson has taken over as the Marketing Manager.
- Manitoba Harvest Welcomes New Marketing Manager to Team
Manitoba Harvest Hemp Foods & Oils has announced that Kelly Saunderson has taken over as the Marketing Manager.
- Manitoba Harvest Welcomes New Marketing Manager to Team
Manitoba Harvest Hemp Foods & Oils has announced that Kelly Saunderson has taken over as the Marketing Manager.
- Martek Signs Sole-Source Supply Agreement with Milk Powder Solutions
Martek Biosciences Corporation has announced that it has entered into a multi-year, sole-source supply agreement with Milk Powder Solutions, based in Australia.
- Martek Signs Sole-Source Supply Agreement with Milk Powder Solutions
Martek Biosciences Corporation has announced that it has entered into a multi-year, sole-source supply agreement with Milk Powder Solutions, based in Australia.
- Martek Signs Sole-Source Supply Agreement with Milk Powder Solutions
Martek Biosciences Corporation has announced that it has entered into a multi-year, sole-source supply agreement with Milk Powder Solutions, based in Australia.
- Martek Signs Sole-Source Supply Agreement with Milk Powder Solutions
Martek Biosciences Corporation has announced that it has entered into a multi-year, sole-source supply agreement with Milk Powder Solutions, based in Australia.
- Jamba, Inc. Reports FY09 Q2 Results
Jamba, Inc., has announced their FY09 Q2 results, reporting total revenue for FY09 Q2 decreased 15.1% to $83.2 million from $98.0 million for FY08 Q2.
- Jamba, Inc. Reports FY09 Q2 Results
Jamba, Inc., has announced their FY09 Q2 results, reporting total revenue for FY09 Q2 decreased 15.1% to $83.2 million from $98.0 million for FY08 Q2.
- Jamba, Inc. Reports FY09 Q2 Results
Jamba, Inc., has announced their FY09 Q2 results, reporting total revenue for FY09 Q2 decreased 15.1% to $83.2 million from $98.0 million for FY08 Q2.
- JLL Rejects Non-Binding Acquisition Proposal From Lonza Group AG
JLL Partners, Inc. and its affiliate, JLL Patheon Holdings, LLC, announced that it will reject the non-binding proposal by Lonza Group AG to acquire all of the outstanding Restricted Voting Shares of Patheon Inc.
- JLL Rejects Non-Binding Acquisition Proposal From Lonza Group AG
JLL Partners, Inc. and its affiliate, JLL Patheon Holdings, LLC, announced that it will reject the non-binding proposal by Lonza Group AG to acquire all of the outstanding Restricted Voting Shares of Patheon Inc.
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- New Company for “Change-The-World” Entrepreneurs™ Launches
- GMP Labs Expands Liquid Nutraceutical Capabilities
- What Parents Should Know About Kids and Supplements
- What Parents Should Know About Kids and Supplements
- Oats Beat Back Cholesterol
- Oats Beat Back Cholesterol
- Seniors: Pump Up for Strong Bones and Heart
- Seniors: Pump Up for Strong Bones and Heart
- Vitamin K2 as MK-7 (MenaQ7®) supplementation - essential for better bone health after organ transplantation
- Vitamin K2 as MK-7 (MenaQ7®) supplementation - essential for better bone health after organ transplantation
|
Premium Ingredients International, the world’s leading supplier of ingredients and flavours to the Food, Beverage, and Nutritional industries, has established PII Food Ingredients to expand distribution into Canada. PII Food Ingredients will operate as a division of Bulk Pharmaceuticals Corporation, Scarborough, Ontario. Bulk has been servicing the Pharmaceutical, Nutraceutical, and Veterinarian Industries for more than 15 years and was acquired by Premium Ingredients International in May 2008.
PII Food Ingredients will focus on a targeted portfolio of core ingredients leveraging Premium’s strengths in vitamins, acidulants, preservatives, and flavour enhancers, in order to further develop the food business in Canada. “We are confident that Premium’s 30 year history of supplying ingredients to the food and beverage industry together with Bulk Pharmaceutical’s customer base in Pharmaceutical, Nutraceutical, and the Veterinary Industry, will provide a winning recipe to expand portfolio offerings and generate new business” said Don Thorp, President of Premium Ingredients International.
“The establishment of PII Food Ingredients will allow us to meet our customer’s demands in the growing and ever changing food, beverage, and nutritional markets. Product will be stocked and shipped out of the same Toronto distribution facility as Bulk allowing us to better service our customers and keep freight costs to a minimum,” Don Thorp added.
“We are very excited to be a part of the Premium Ingredients family and look forward to growing the food side of the business in Canada” said Rod Garrett, President of Bulk Pharmaceuticals, Inc. Both companies share the same dedication to quality and service, so combined we will become a leading supplier in the Canadian market,” added Rod Garrett.
Robert T. Chiasson has been appointed Senior Account Manager for the newly created division and will be responsible for developing the business in Canada. Robert is based in the Toronto area and has more than 20 years experience in the Canadian Food and Beverage Industry.
About Premium Ingredients International
Premium Ingredients International, founded originally in 1978, is one the largest food ingredient distributors in the world. It is the largest importer of Vitamin C, B1, B2, Taurine and many other ingredients for the North American Food and Nutritional markets. Customers have come to know Premium Ingredients as the leader in providing superior customer service and market expertise. Premium Ingredients International is headquartered in Carol Stream, IL with offices in Utah, Missouri, New Jersey, London, and Toronto. www.premiumingredients.com
About Bulk Pharmaceuticals, Inc.
Bulk Pharmaceuticals was established in 1995 to supply raw materials to the Pharmaceutical, Nutraceutical, and Veterinary Industries. With over 25 years of experience in international trade and a strong presence in China, Bulk Pharmaceuticals has shown it can meet the demand and supply of this growing industry. Bulk Pharmaceuticals is located at 445 Milner Ave., Unit #11, Scarborough, Ontario, Canada M1B 2K4. www.bulkpharma.ca |